Prenetics Global Limited (PRE)

Market Cap	165.07M
Revenue (ttm)	77.08M
Net Income (ttm)	-46.55M
Shares Out	13.53M
EPS (ttm)	-3.52
PE Ratio	n/a
Forward PE	11.30
Dividend	n/a
Ex-Dividend Date	n/a

Volume	132,922
Open	13.52
Previous Close	13.47
Day's Range	12.11 - 13.52
52-Week Range	3.10 - 17.99
Beta	0.35
Analysts	Buy
Price Target	32.00 (+162.3%)
Earnings Date	Nov 10, 2025

About PRE

Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand. The company is also involved in the operation of CircleDNA, a consumer genetic testing brand that uses next-generation sequencing (NGS) technology to provide comprehensive insights into health, wellness, and genetic predispositions. Pren...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2014
• Employees: 285
• Stock Exchange: NASDAQ
• Ticker Symbol: PRE
• Website: https://www.prenetics.com

Financial Performance

In 2024, Prenetics Global's revenue was $30.62 million, an increase of 40.83% compared to the previous year's $21.74 million. Losses were -$46.30 million, -26.18% less than in 2023.

Analyst Summary

According to one analyst, the rating for PRE stock is "Buy" and the 12-month stock price target is $32.0.

Price Target

$32.0

(162.30% upside)

Analyst Consensus: Buy